ArticleJournal of clinical hypertension (Greenwich, Conn.)2026
Elevated Cumulative Blood Pressure is Associated With Cognitive Decline: A Nationwide Population-Based Cohort Study.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Methodological and Statistical Considerations in Assessing the Association Between Cumulative Blood Pressure and Cognitive Decline.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Understanding the Clinical Meaning of Cumulative Blood Pressure Exposure in Cognitive Outcomes.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Cumulative Blood Pressure as a Marker of Early Cognitive Decline.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Given that the evidence of a longitudinal association between cumulative blood pressure (BP) levels and cognitive function is inadequate and inconclusive, we conducted this study to determine whether higher cumulative BP was independently associated with subsequent cognitive decline and to evaluate the potential dose-response relationship between them. This cohort study used data from the 2011 to 2018 China Health and Retirement Longitudinal Study (CHARLS). All cognitive test scores were transformed into standardized z-scores, with negative values indicating worse performance. We used linear mixed models and restricted cubic splines to assess the association of cumulative BP levels with cognitive function. A total of 7877 participants were included (mean [SD] age, 58.4 [9.0] years; 46.8% men; median follow-up duration, 6.9 [IQR, 3.8-7.0] years). After controlling for multiple factors, compared with the lowest quartile, the highest quartiles of cumulative systolic BP (SBP, β = -0.096 SD/year, 95% CI: -0.149 to -0.044) and pulse pressure (PP, β = -0.099 SD/year, 95% CI: -0.154 to -0.043) were independently associated with faster cognitive decline, whereas no significant association was observed for diastolic BP (DBP, β = -0.023 SD/year, 95% CI: -0.075 to 0.029). Each SD increment in cumulative SBP and PP, but not DBP, was also associated with accelerated cognitive decline. Additionally, nonlinear dose-response relationships were observed between cumulative SBP and DBP levels and the rate of cognitive decline (all p < 0.05). In conclusion, elevated cumulative SBP and PP, but not DBP, were independently associated with accelerated cognitive decline among middle-aged and older Chinese adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.